Lylah Drummond-Clarke

Ms. Lylah Drummond-Clarke

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2023 in The EMBO Journal
Verified
Journal Article
Open access
ASAlmudena Serrano‐Benitez
Almudena Serrano‐Benitez
SWSophie E Wells
Sophie E Wells
LDLylah Drummond-Clarke
Lylah Drummond-Clarke
LRLilian C Russo
Lilian C Russo
JTJohn Christopher Thomas
John Christopher Thomas
KCKeith W Caldecott
Keith W Caldecott
DNA single‐strand breaks (SSBs) disrupt DNA replication and induce chromosome breakage. However, whether SSBs induce chromosome breakage when present behind replication forks or ahead of replication forks is unclear. To address this question, we exploited an exquisite sensitivity of SSB repair‐defective human cells lacking PARP activity or XRCC1 to the thymidine analogue 5‐chloro‐2′‐deoxyuridine (CldU). We show that incubation with CldU in these cells results in chromosome breakage, sister chromatid exchange, and cytotoxicity by a mechanism that depends on the S phase activity of uracil DNA glycosylase (UNG). Importantly, we show that CldU incorporation in one cell cycle is cytotoxic only during the following cell cycle, when it is present in template DNA. In agreement with this, while UNG induces SSBs both in nascent strands behind replication forks and in template strands ahead of replication forks, only the latter trigger fork collapse and chromosome breakage. Finally, we show that BRCA‐defective cells are hypersensitive to CldU, either alone and/or in combination with PARP inhibitor, suggesting that CldU may have clinical utility.

6 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Louise BroughLouise Brough
Louise Brough
Gail ReesGail Rees
Gail Rees
LDLylah Drummond-Clarke
Lylah Drummond-Clarke
JMJennifer Elizabeth McCallum
Jennifer Elizabeth McCallum
ETElisabeth Taylor
Elisabeth Taylor
SWSteven Walker
Steven Walker
Dietary supplementation is commonly used by athletes to gain muscle mass, enhance performance, and improve recovery. Most adults engage in insufficient physical activity. Yet healthy muscles are also critical for activities of daily living (ADLs), maintaining a good quality of life and positive ageing. There is growing interest in whether dietary supplementation is of value, particularly among subgroups such as the occasionally active, the ill and elderly, and peri- and menopausal women. By focusing on function, performance, mass and strength, ADLs, exercise-induced muscle damage and delayed onset muscle soreness, this review sought to examine muscle health through a nutritional lens. Further, to look at the potential benefits and harms of some commonly proposed dietary supplements in non-athlete adults, while exploring the emerging role of the gut–muscle axis. Inflammation appears central to cellular events. Several supplements were identified that, alone or in combination, may help optimise muscle health, particularly when combined with exercise or where a deficit may exist. Although supportive evidence is emerging, real-world clinical benefits remain to be substantiated. Though dietary supplements are generally safe, their regulation is less stringent than for medicines. Adherence to recommended dosage, seeking medical advice regarding possible side effects/interactions, and obtaining supplies from reliable sources are recommended.

5 November 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
AKAndrew Krentz
Andrew Krentz
OKOleksii Kozhevnikov
Oleksii Kozhevnikov
JMJennifer Elizabeth McCallum
Jennifer Elizabeth McCallum
LDLylah Drummond-Clarke
Lylah Drummond-Clarke
MFMegan Fant
Megan Fant
SWSteven Walker
Steven Walker
Metabolic syndrome (MetS) encompasses a spectrum of disease pathologies that include dyslipidaemia, insulin resistance, hypertension, obesity, and inflammation. The rising prevalence of MetS and the associated morbidity and mortality represent a growing burden on global healthcare. MetS’s hallmarks are readily quantified and can be used to assess development and progression of the syndrome. Nutraceuticals, bioactive compounds derived from natural sources such as plants, fruits, cultures and grains, have a potential role in protection against cardiometabolic diseases. Relevant actions of nutraceuticals include their antioxidant, probiotic, anti-inflammatory, insulin-sensitising, lipid-modifying, anti-adiposity, and endothelial protective functions. This review explores the evidence for common nutrient deficiencies in metabolic syndrome alongside their role in preventing and modifying the complex elements that characterise this prevalent disease cluster.